UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2018
INNOSPEC INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 1-13879
Delaware | 98-0181725 | |
(State or other jurisdiction of incorporation) |
(IRS Employer Identification No.) |
8310 South Valley Highway
Suite 350
Englewood, Colorado, 80112
(Address of principal executive offices, including zip code)
(303)792-5554
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 | Results of Operations and Financial Condition. |
On November 6, 2018, Innospec Inc. issued a press release (the Press Release) announcing its financial results for the quarter ended September 30, 2018.
Item 7.01 | Regulation FD Disclosure. |
The Press Release also announced that on November 2, 2018, the Companys Board of Directors declared a semi-annual dividend of $0.45 per share on the Companys common stock (IOSP). The dividend will be paid on November 29, 2018 to holders of record on November 19, 2018.
Item 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits. |
EXHIBIT INDEX
Number |
Description |
Method of Filing | ||
99.1 | Press Release dated November 6, 2018 announcing Innospec Inc.s financial results for the quarter ended September 30, 2018 | Filed Herewith |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOSPEC INC. | ||
By: | David Jones | |
David B. Jones | ||
VP, General Counsel and CCO |
Date: November 7, 2018
3